“ Dexmedetomidine Inhibits Inflammation and Angiogenesis and Alleviates Esophageal Cancer Progression through ITGA6 PI3K AKT Pathway: Dexmedetomidine Inhibits Esophageal Cancer Progression”. Indian Journal of Experimental Biology (IJEB) 64, no. 01 (February 16, 2026): 15–32. Accessed May 13, 2026. https://or.niscpr.res.in/index.php/IJEB/article/view/22881.